Diabetes in urban African-Americans. XVI. Overcoming clinical inertia improves glycemic control in patients with type 2 diabetes

Diabetes Care

Volumn 22, Issue 9, 1999, Pages 1494-1500

  Cook, Curtiss B ^a   Ziemer, David C ^b   El Kebbi, Imad M ^b   Gallina, Daniel L ^b   Dunbar, Virginia G ^b   Ernst, Kris L ^b   Phillips, Lawrence S ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; ARTICLE; DIET THERAPY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGRO; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; PATIENT CARE;

AFRICAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; REGISTRIES; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; URBAN HEALTH;

EID: 0032841673     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.22.9.1494     Document Type: Article

References (21)

1. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-989, 1993
2. Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, Kojima Y, Furuyoshi N, Shichiri M: Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diab Res Clin Pract 28:103-117, 1995
3. Abraira C, Colwell JA, Nuttall FQ, Sawin CT, Nagel NJ, Comstock JP, Emanuele NV, Levin SR, Henderson W, Lee HS, VA CSDM Group: Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM). Diabetes Care 18:1113-1123, 1995
4. UK Prospective Diabetes Study (UKPDS) Group: Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352:854-865, 1998
5. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 329:1456-1462, 1993
6. Diabetic Retinopathy Study Group: Photocoagulation treatment of proliferative diabetic retinopathy: clinical application of Diabetic Retinopathy Study (DRS) findings. DRS Report No. 8. Ophthalmology 88: 583-600, 1981
7. Litzelman DK, Slemenda CW, Langefeld CD, Hays LM, Welch MA, Bild DE, Ford ES, Vinicor F: Reduction of lower extremity clinical abnormalities in patients with non-insulin-dependent diabetes mellitus. Ann Intern Med 119:36-41, 1993
8. Ravid M, Brosh D, Levi Z, Bar-Dayan Y, Ravid D, Rachmani R: Use of enalapril to attenuate decline in renal function in normotensive, normoalbuminuric patients with type 2 diabetes mellitus. Ann Int Med 128:982-988, 1998
9. Peters AL, Legorreta AP, Ossorio RC, Davidson MB: Quality of outpatient care provided to diabetic patients: a health maintenance organization experience. Diabetes Care 19:601-606, 1996
10. Fain JA, Melkus GD: Nurse practitioner practice patterns based on standards of medical care for patients with diabetes. Diabetes Care 17:879-881, 1994
11. Medicare: Most beneficiaries with diabetes do not receive recommended monitoring services. Washington, DC, 1997 (General Accounting Office/HEHS-97-48)
12. Beckles GLA, Englegau MM, Narayan KMV, Herman WH, Aubert RE, Williamson DF: Population-based assessment of the level of care among adults with diabetes in the U.S. Diabetes Care 21:1432-1438, 1998
13. Greenfield S, Rogers W, Mangotich M, Carnery M, Tarlov AR: Outcomes of patients with hypertension and non-insulin-dependent diabetes mellitus treated by different systems and specialties: results from the Medical Outcomes Study. JAMA 274:1436-1444, 1995
14. El-Kebbi IM, Ziemer DC, Musey VC, Gallina DL, Bernard AM, Phillips LS: Diabetes in urban African-Americans. IX. Provider adherence to management protocols. Diabetes Care 20:698-703, 1997
15. Gruesser M, Bott U, Ellerman P, Kronsbein R, Joergens V: Evaluation of a structured treatment and teaching program for non-insulin-treated type II diabetic outpatients in Germany after nationwide introduction of reimbursement policy for physicians. Diabetes Care 16:1268-1275, 1993
16. Peters AL, Davidson MB: Application of a diabetes managed care program. Diabetes Care 21:1037-1043, 1998
17. Aubert RE, Herman WH, Waters J, Moore W, Sutton D, Peterson BL, Bailey CM, Koplan JP: Nurse care management to improve glycemic control in diabetic patients in a health maintenance organization. Ann Intern Med 129:605-612, 1998
18. Carter JS, Pugh JA, Monterrosa A: Non-insulin dependent diabetes mellitus in minorities in the United States. Ann Intern Med 125:221-232, 1996
19. Harris MI, Eastman RC, Cowie CC, Flegal KM, Eberhardt MS: Racial and ethnic differences in glycemic control of adults with type 2 diabetes. Diabetes Care 22:403-408, 1999
20. Ziemer DC, Goldschmid MG, Musey VC, Domin WS, Thule PM, Gallina DL, Phillips LS: Diabetes in urban African Americans. III. Management of type II diabetes in a municipal hospital setting. Am J Med 101:25-33, 1996
21. Goldschmid MG, Domin WS, Ziemer DC, Gallina DL, Phillips LS: Diabetes in urban African-Americans. II. High prevalence of microalbuminuria and nephropathy in African-Americans with diabetes. Diabetes Care 18:955-961, 1995